All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells.

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F04%3AI0000035" target="_blank" >RIV/00023736:_____/04:I0000035 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells.

  • Original language description

    The effects of Imatinib mesylate on CML cell lines K562 and JURL-MK1 were compared. Imatinib mesylate arrested both cell lines in G0/G1 phase and induced apoptosis that proceeded faster in JURL-MK1 cells and occurred in larger fraction of cell population. In addition, the erythroid differentiation was triggered in both cell lines. Apoptosis and the erythroid differentiation are parallel effects of Imatinib mesylate and their relative contributions and kinetics are related to the differentiation stage oftreated cells.

  • Czech name

    Rychlá apoptóza a erytroidní diferenciace vyvolané účinkem imatinib mesylátu na buněčné linie K 562 a JURL-MK1

  • Czech description

    Byly porovnány účinky Imatinib mesylátu na CML buněčné linie K562 a JURL-MK1. U obou linií došlo k zastavení buněčného cyklu v G0/G1 fázi a byla indukována apoptoza jež u buněk JURL-MK1 probíhala rychleji a u větší části buněčné populace. Dále byla u obou linií navozena erytroidní diferenciace. Apoptoza a erytroidní diferenciace jsou paralelními účinky Imatinib mesylátu jejichž relativní příspěvky a kinetiky jsou závislé na diferenciačním stavu buněk.

Classification

  • Type

    D - Article in proceedings

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NL7681" target="_blank" >NL7681: Exprimental pharmacotherapy of chronic myelogenous leukemia the proteomic approach</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2004

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Article name in the collection

    5th interdisciplinary conference mechanisms of cell death and disease : advances in therapeutic intervention and drug development

  • ISBN

  • ISSN

  • e-ISSN

  • Number of pages

    1

  • Pages from-to

    36

  • Publisher name

    ESH and MD Anderson Cancer Center

  • Place of publication

    Cascais

  • Event location

    Cascais

  • Event date

    Oct 22, 2004

  • Type of event by nationality

    EUR - Evropská akce

  • UT code for WoS article